DE2107989A1 - N-(Furyl-methy])-morphinane, deren Säureadditionssalze sowie Verfahren zu deren Herstellung - Google Patents

N-(Furyl-methy])-morphinane, deren Säureadditionssalze sowie Verfahren zu deren Herstellung

Info

Publication number
DE2107989A1
DE2107989A1 DE19712107989 DE2107989A DE2107989A1 DE 2107989 A1 DE2107989 A1 DE 2107989A1 DE 19712107989 DE19712107989 DE 19712107989 DE 2107989 A DE2107989 A DE 2107989A DE 2107989 A1 DE2107989 A1 DE 2107989A1
Authority
DE
Germany
Prior art keywords
formula
methyl
morphinan
compounds
addition salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712107989
Other languages
German (de)
English (en)
Inventor
Herbert Dr.; Langbein Adolf Dr.; Wick Helmut Dr.; Stockhaus Klaus Dr.;65O7Ingelheim Merz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Priority to DE19712107989 priority Critical patent/DE2107989A1/de
Priority to US00224973A priority patent/US3793329A/en
Priority to RO7200076826A priority patent/RO63019A/ro
Priority to PH13267A priority patent/PH10385A/en
Priority to CH755175A priority patent/CH567503A5/xx
Priority to RO7200076825A priority patent/RO63262A/ro
Priority to RO7200069780A priority patent/RO62412A/ro
Priority to RO7200076824A priority patent/RO63012A/ro
Priority to CH219772A priority patent/CH567501A5/xx
Priority to BG019747A priority patent/BG20584A3/xx
Priority to SU1939073A priority patent/SU481155A3/ru
Priority to HUBO1351A priority patent/HU162947B/hu
Priority to CS3427*A priority patent/CS166808B2/cs
Priority to CS3425*A priority patent/CS166806B2/cs
Priority to SU1750069A priority patent/SU440837A1/ru
Priority to CS1036A priority patent/CS166805B2/cs
Priority to ES72399875A priority patent/ES399875A1/es
Priority to CS3426*A priority patent/CS166807B2/cs
Priority to BG021205A priority patent/BG22833A3/xx
Priority to BG021203A priority patent/BG20356A3/xx
Priority to BG021204A priority patent/BG20357A3/xx
Priority to SU1939076A priority patent/SU466658A3/ru
Priority to IL38788A priority patent/IL38788A/xx
Priority to GB765072A priority patent/GB1379781A/en
Priority to IE206/72A priority patent/IE36116B1/xx
Priority to AT01364/72A priority patent/AT312588B/de
Priority to NO491/72A priority patent/NO134055C/no
Priority to AT108373A priority patent/AT318600B/de
Priority to DK76972A priority patent/DK136721C/da
Priority to DD160981A priority patent/DD96484A5/xx
Priority to AU39140/72A priority patent/AU468490B2/en
Priority to PL1972153546A priority patent/PL77393B1/pl
Priority to CA135,013A priority patent/CA969180A/en
Priority to NL7202153A priority patent/NL7202153A/xx
Priority to FR7205575A priority patent/FR2125599B1/fr
Priority to SE02039/72A priority patent/SE363826B/xx
Priority to AT108273A priority patent/AT318599B/de
Priority to BE779582A priority patent/BE779582A/xx
Priority to ZA721072A priority patent/ZA721072B/xx
Publication of DE2107989A1 publication Critical patent/DE2107989A1/de
Priority to SU1940421A priority patent/SU488411A3/ru
Priority to ES420628A priority patent/ES420628A1/es
Priority to ES420630A priority patent/ES420630A1/es
Priority to ES420629A priority patent/ES420629A1/es
Priority to US426215A priority patent/US3865943A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19712107989 1971-02-19 1971-02-19 N-(Furyl-methy])-morphinane, deren Säureadditionssalze sowie Verfahren zu deren Herstellung Pending DE2107989A1 (de)

Priority Applications (44)

Application Number Priority Date Filing Date Title
DE19712107989 DE2107989A1 (de) 1971-02-19 1971-02-19 N-(Furyl-methy])-morphinane, deren Säureadditionssalze sowie Verfahren zu deren Herstellung
US00224973A US3793329A (en) 1971-02-19 1972-02-09 N-(furyl-methyl)-3-oxy-morphinans and salts thereof
RO7200076826A RO63019A (fr) 1971-02-19 1972-02-10 Procede pour la preparation des n-(furrylmethyl)-morphinanes
PH13267A PH10385A (en) 1971-02-19 1972-02-14 N-(furyl-methyl)-3-oxy-morphinans and salts thereof
CH755175A CH567503A5 (US07368562-20080506-C00024.png) 1971-02-19 1972-02-16
RO7200076825A RO63262A (fr) 1971-02-19 1972-02-16 Procede pour la preparation des n-(furylmethyle)-morphinanes
RO7200069780A RO62412A (fr) 1971-02-19 1972-02-16 Procede pour la preparation des n-(furylmethyle)-morphinanes
RO7200076824A RO63012A (fr) 1971-02-19 1972-02-16 Procede pour la preparation des n-(furrylmethyle)-morphinanes
CH219772A CH567501A5 (US07368562-20080506-C00024.png) 1971-02-19 1972-02-16
SU1939076A SU466658A3 (ru) 1971-02-19 1972-02-17 Способ получени -(фурилметил) -морфинанов
SU1939073A SU481155A3 (ru) 1971-02-19 1972-02-17 Способ получени -(фурил-метил)морфинанов
HUBO1351A HU162947B (US07368562-20080506-C00024.png) 1971-02-19 1972-02-17
CS3427*A CS166808B2 (US07368562-20080506-C00024.png) 1971-02-19 1972-02-17
CS3425*A CS166806B2 (US07368562-20080506-C00024.png) 1971-02-19 1972-02-17
SU1750069A SU440837A1 (US07368562-20080506-C00024.png) 1972-02-17
CS1036A CS166805B2 (US07368562-20080506-C00024.png) 1971-02-19 1972-02-17
ES72399875A ES399875A1 (es) 1971-02-19 1972-02-17 Procedimiento para la preparacion de n-(furil-metil)-morfi-nanos.
CS3426*A CS166807B2 (US07368562-20080506-C00024.png) 1971-02-19 1972-02-17
BG021205A BG22833A3 (bg) 1971-02-19 1972-02-17 Метод за получаване на n-(фурил-метил)-морфинани и техните присъединителни с киселини соли
BG021203A BG20356A3 (bg) 1971-02-19 1972-02-17 Метод за получаване на n-(фурил-метил)- морфани и техни присъединителни с киселини соли
BG021204A BG20357A3 (bg) 1971-02-19 1972-02-17 Метод за получаване на n-(фурил-метил)-морфинани и техни присъединителни с киселини соли
BG019747A BG20584A3 (bg) 1971-02-19 1972-02-17 Метод за получаване на n-<фурил-метил,порфинани и на техни присъединителни с киселинни соли
DK76972A DK136721C (da) 1971-02-19 1972-02-18 Analogifremgangsmaade til fremstilling af n-(furyl-methyl)-morphinaner og deres syreadditionssalte
NL7202153A NL7202153A (US07368562-20080506-C00024.png) 1971-02-19 1972-02-18
IE206/72A IE36116B1 (en) 1971-02-19 1972-02-18 Furylmethyl morphinane derivatives and pharmaceutical compositions containing them
AT01364/72A AT312588B (de) 1971-02-19 1972-02-18 Verfahren zur herstellung von neuen,racemischen oder optisch aktiven n-(furyl-methyl)-morphinanen und deren saeureadditionssalzen
NO491/72A NO134055C (US07368562-20080506-C00024.png) 1971-02-19 1972-02-18
AT108373A AT318600B (de) 1971-02-19 1972-02-18 Verfahren zur Herstellung von neuen, racemischen oder optisch aktiven N-(Furyl-methyl)-morphinanen und deren Säureadditionssalzen
IL38788A IL38788A (en) 1971-02-19 1972-02-18 N-(furylmethyl)-morphinanes,acid addition salts thereof and processes for their production
DD160981A DD96484A5 (US07368562-20080506-C00024.png) 1971-02-19 1972-02-18
AU39140/72A AU468490B2 (en) 1971-02-19 1972-02-18 Furylmethyl morphinane derivatives and pharmaceutical compositions containing them
PL1972153546A PL77393B1 (US07368562-20080506-C00024.png) 1971-02-19 1972-02-18
CA135,013A CA969180A (en) 1971-02-19 1972-02-18 N-(furyl-methyl)-morphinanes, the acid addition salts as well as processes for production thereof
GB765072A GB1379781A (en) 1971-02-19 1972-02-18 Furylmethyl morphinane derivatives and pharmaceutical compositions containing them
FR7205575A FR2125599B1 (US07368562-20080506-C00024.png) 1971-02-19 1972-02-18
SE02039/72A SE363826B (US07368562-20080506-C00024.png) 1971-02-19 1972-02-18
AT108273A AT318599B (de) 1971-02-19 1972-02-18 Verfahren zur Herstellung von neuen, racemischen oder optisch aktiven N-(Furyl-methyl)-morphinanen und deren Säureadditionssalzen
BE779582A BE779582A (fr) 1971-02-19 1972-02-18 N-(furylmethyl)-morphinanes, leurs sels d'addition avec des acides et procedes pour les fabriquer
ZA721072A ZA721072B (en) 1971-02-19 1972-02-18 Improvements relating to n-(furyl-methyl)-morphinanes
SU1940421A SU488411A3 (ru) 1971-02-19 1973-06-25 Способ получени -(фурил-метил)морфинанов
ES420628A ES420628A1 (es) 1971-02-19 1973-11-17 Procedimiento para la preparacion de n-(furiu-metil)-morfi-nanos.
ES420630A ES420630A1 (es) 1971-02-19 1973-11-17 Procedimiento para la preparacion de n-(furil-metil)-morfi-nanos.
ES420629A ES420629A1 (es) 1971-02-19 1973-11-17 Procedimiento para la preparacion de n-(furil-metil)-morfi-nanos.
US426215A US3865943A (en) 1971-02-19 1973-12-19 Pharmaceutical compositions containing an n-(furyl-methyl)-3-oxy-morphinan and method of use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712107989 DE2107989A1 (de) 1971-02-19 1971-02-19 N-(Furyl-methy])-morphinane, deren Säureadditionssalze sowie Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
DE2107989A1 true DE2107989A1 (de) 1972-09-07

Family

ID=5799263

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712107989 Pending DE2107989A1 (de) 1971-02-19 1971-02-19 N-(Furyl-methy])-morphinane, deren Säureadditionssalze sowie Verfahren zu deren Herstellung

Country Status (25)

Country Link
US (1) US3793329A (US07368562-20080506-C00024.png)
AT (3) AT318600B (US07368562-20080506-C00024.png)
AU (1) AU468490B2 (US07368562-20080506-C00024.png)
BE (1) BE779582A (US07368562-20080506-C00024.png)
BG (4) BG20356A3 (US07368562-20080506-C00024.png)
CA (1) CA969180A (US07368562-20080506-C00024.png)
CH (2) CH567503A5 (US07368562-20080506-C00024.png)
CS (4) CS166807B2 (US07368562-20080506-C00024.png)
DD (1) DD96484A5 (US07368562-20080506-C00024.png)
DE (1) DE2107989A1 (US07368562-20080506-C00024.png)
DK (1) DK136721C (US07368562-20080506-C00024.png)
ES (4) ES399875A1 (US07368562-20080506-C00024.png)
FR (1) FR2125599B1 (US07368562-20080506-C00024.png)
GB (1) GB1379781A (US07368562-20080506-C00024.png)
HU (1) HU162947B (US07368562-20080506-C00024.png)
IE (1) IE36116B1 (US07368562-20080506-C00024.png)
IL (1) IL38788A (US07368562-20080506-C00024.png)
NL (1) NL7202153A (US07368562-20080506-C00024.png)
NO (1) NO134055C (US07368562-20080506-C00024.png)
PH (1) PH10385A (US07368562-20080506-C00024.png)
PL (1) PL77393B1 (US07368562-20080506-C00024.png)
RO (4) RO63019A (US07368562-20080506-C00024.png)
SE (1) SE363826B (US07368562-20080506-C00024.png)
SU (3) SU466658A3 (US07368562-20080506-C00024.png)
ZA (1) ZA721072B (US07368562-20080506-C00024.png)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2229770A1 (de) * 1972-06-19 1974-01-10 Boehringer Sohn Ingelheim N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
DE2230154A1 (de) * 1972-06-21 1974-01-17 Boehringer Sohn Ingelheim N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
US3923987A (en) * 1972-08-07 1975-12-02 Boehringer Sohn Ingelheim Pharmaceutical compositions containing an n-furyl-or thienyl-methyl)- -oxy-7,8 -dihydro-normorphinone or norcodeinone and method of use
DE2238839A1 (de) * 1972-08-07 1974-02-14 Boehringer Sohn Ingelheim Neue morphinon-derivate, deren saeureadditionssalze, verfahren zu ihrer herstellung sowie ihre verwendung zur herstellung von arzneimitteln
US3975368A (en) * 1972-09-14 1976-08-17 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing an N-(furyl- or thienyl-methyl)-desoxy-normorphine or norcodeine and method of use
DE2245141A1 (de) * 1972-09-14 1974-03-21 Boehringer Sohn Ingelheim Neue n-(heteroarylmethyl)-desoxynormorphine und -norcodeine, deren saeureadditionssalze, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
US4232026A (en) * 1978-07-20 1980-11-04 Merck & Co., Inc. Diazaditwistanes, and pharmaceutical compositions for treating pain in warm blooded animals containing them
US7923454B2 (en) * 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
GB0421687D0 (en) 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
WO2007137785A2 (en) * 2006-05-25 2007-12-06 Alpharma (Bermuda) Investments Ltd Process useful in the preparation of morphinan antagonists
GB2471800B (en) * 2006-05-25 2011-03-09 Alpharma Preparation of N-alkylated morphinans by reduction of an iminium group
KR100780932B1 (ko) * 2006-05-30 2007-11-30 엠텍비젼 주식회사 컬러 보간 방법 및 장치
US10766864B2 (en) 2015-05-08 2020-09-08 Nektar Therapeutics Morphinan derivatives for the treatment of neuropathic pain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL99456C (US07368562-20080506-C00024.png) * 1957-12-04

Also Published As

Publication number Publication date
IL38788A0 (en) 1972-04-27
BE779582A (fr) 1972-08-18
NL7202153A (US07368562-20080506-C00024.png) 1972-08-22
AT318599B (de) 1974-10-25
RO63019A (fr) 1978-05-15
CS166806B2 (US07368562-20080506-C00024.png) 1976-03-29
BG22833A3 (bg) 1977-04-20
FR2125599B1 (US07368562-20080506-C00024.png) 1975-10-31
SU481155A3 (ru) 1975-08-15
DD96484A5 (US07368562-20080506-C00024.png) 1973-03-20
SE363826B (US07368562-20080506-C00024.png) 1974-02-04
IL38788A (en) 1975-05-22
RO63262A (fr) 1978-06-15
SU440837A3 (US07368562-20080506-C00024.png) 1974-08-25
HU162947B (US07368562-20080506-C00024.png) 1973-05-28
BG20357A3 (bg) 1975-11-05
DK136721C (da) 1978-04-24
ATA136472A (US07368562-20080506-C00024.png) 1973-12-15
PH10385A (en) 1977-03-02
RO62412A (fr) 1978-03-15
ZA721072B (en) 1973-10-31
AU3914072A (en) 1973-08-23
CA969180A (en) 1975-06-10
RO63012A (fr) 1978-05-15
NO134055C (US07368562-20080506-C00024.png) 1976-08-11
IE36116L (en) 1972-08-19
CS166807B2 (US07368562-20080506-C00024.png) 1976-03-29
PL77393B1 (US07368562-20080506-C00024.png) 1975-04-30
CH567503A5 (US07368562-20080506-C00024.png) 1975-10-15
CS166805B2 (US07368562-20080506-C00024.png) 1976-03-29
AT318600B (de) 1974-10-25
NO134055B (US07368562-20080506-C00024.png) 1976-05-03
FR2125599A1 (US07368562-20080506-C00024.png) 1972-09-29
DK136721B (da) 1977-11-14
SU488411A3 (ru) 1975-10-15
US3793329A (en) 1974-02-19
ES399875A1 (es) 1974-12-01
IE36116B1 (en) 1976-08-18
ES420630A1 (es) 1976-05-01
AT312588B (de) 1974-01-10
CS166808B2 (US07368562-20080506-C00024.png) 1976-03-29
ES420628A1 (es) 1976-05-01
ES420629A1 (es) 1976-05-01
BG20584A3 (bg) 1975-12-05
CH567501A5 (US07368562-20080506-C00024.png) 1975-10-15
AU468490B2 (en) 1976-01-15
SU466658A3 (ru) 1975-04-05
BG20356A3 (bg) 1975-11-05
GB1379781A (en) 1975-01-08

Similar Documents

Publication Publication Date Title
DE2105743C3 (de) 2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
DE2558501C2 (US07368562-20080506-C00024.png)
DE2265255C2 (de) 2-Aminoäthylhexahydrophenanthren-Derivate und deren Säureadditionssalze
DE2411382A1 (de) Neue 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
DE1958201C3 (de) Substituierte 2- [N-(2,6-dichlorphenyl)-N-aUylamino] -imidazoline-^), deren Säureadditionssalze, Verfahren zu ihrer Herstellung und deren Verwendung bei der Bekämpfung von Schmerzzuständen
CH615677A5 (US07368562-20080506-C00024.png)
DE2107989A1 (de) N-(Furyl-methy])-morphinane, deren Säureadditionssalze sowie Verfahren zu deren Herstellung
DE2108954A1 (en) 2-(furylmethyl)-6,7-benzomorphans - useful as cns active agents
DE2229695A1 (de) 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2002840A1 (de) 2,3,5-trisubstit,-2&#39;-Hydroxy-6,7-benzomorphane und Verfahren zu deren Herstellung
DE3002367A1 (de) 2-substituierte trans-5-aryl-2,3,4,4a,5, 9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu indole
DE2254298A1 (de) Neue (heteroarylmethyl)-normorphine, deren saeureadditionssalze, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
DE2044172C3 (de) Pyrrolderivate, ein Verfahren zu ihrer Herstellung und Arzneimittel
DD229407A5 (de) Verfahren zur herstellung von piperidindion-derivaten, die als myocard-schutz eine antiarrhytmische aktivitaet aufweisen
DE3888811T2 (de) Tricyclische Carbamate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung.
DE2619617C2 (US07368562-20080506-C00024.png)
DE1620295C3 (de) Isochinolo eckige Klammer auf 2,1-d eckige Klammer zu benzo eckige Klammer auf 1,4 eckige Klammer zu diazepin-6-one
DE2230154A1 (de) N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
DE2217420C3 (de) N-Thienylmethyl-Heterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2229770A1 (de) N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
EP0000013A1 (de) 4-Phenyl-8-amino-tetrahydroisochinoline, diese enthaltende pharmazeutische Präparate und Verfahren zur Herstellung dieser Präparate
AT213877B (de) Verfahren zur Herstellung von neuen basisch substituierten Diphenylalkan-Derivaten und deren Säureadditionssalzen bzw. quartären Ammoniumsalzen
DE2200596A1 (de) N-(furyl-methyl)-2&#39;-hydroxy-5-phenyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2245141A1 (de) Neue n-(heteroarylmethyl)-desoxynormorphine und -norcodeine, deren saeureadditionssalze, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
DE1545950A1 (de) Verfahren zur Herstellung von substituierten Propan-Verbindungen

Legal Events

Date Code Title Description
OHA Expiration of time for request for examination